189 related articles for article (PubMed ID: 2224866)
1. Pharmacokinetic analysis of immunotoxin uptake in solid tumors: role of plasma kinetics, capillary permeability, and binding.
Sung C; Youle RJ; Dedrick RL
Cancer Res; 1990 Nov; 50(22):7382-92. PubMed ID: 2224866
[TBL] [Abstract][Full Text] [Related]
2. The spatial distribution of immunotoxins in solid tumors: assessment by quantitative autoradiography.
Sung C; Dedrick RL; Hall WA; Johnson PA; Youle RJ
Cancer Res; 1993 May; 53(9):2092-9. PubMed ID: 8481911
[TBL] [Abstract][Full Text] [Related]
3. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML
Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407
[TBL] [Abstract][Full Text] [Related]
4. Coupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroids.
Wenning LA; Murphy RM
Biotechnol Bioeng; 1999 Mar; 62(5):562-75. PubMed ID: 10099565
[TBL] [Abstract][Full Text] [Related]
5. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.
Sung C; Shockley TR; Morrison PF; Dvorak HF; Yarmush ML; Dedrick RL
Cancer Res; 1992 Jan; 52(2):377-84. PubMed ID: 1728409
[TBL] [Abstract][Full Text] [Related]
6. Recombinant immunotoxins directed against the c-erb-2/HER2/neu oncogene product: in vitro cytotoxicity, pharmacokinetics, and in vivo efficacy studies in xenograft models.
Rosenblum MG; Shawver LK; Marks JW; Brink J; Cheung L; Langton-Webster B
Clin Cancer Res; 1999 Apr; 5(4):865-74. PubMed ID: 10213223
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
[TBL] [Abstract][Full Text] [Related]
8. Targeting of transferrin receptors in nude mice bearing A431 and LS174T xenografts with [18F]holo-transferrin: permeability and receptor dependence.
Aloj L; Jogoda E; Lang L; Caracò C; Neumann RD; Sung C; Eckelman WC
J Nucl Med; 1999 Sep; 40(9):1547-55. PubMed ID: 10492378
[TBL] [Abstract][Full Text] [Related]
9. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
[TBL] [Abstract][Full Text] [Related]
10. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice.
Baxter LT; Zhu H; Mackensen DG; Jain RK
Cancer Res; 1994 Mar; 54(6):1517-28. PubMed ID: 8137258
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells.
Blakey DC; Skilleter DN; Price RJ; Watson GJ; Hart LI; Newell DR; Thorpe PE
Cancer Res; 1988 Dec; 48(24 Pt 1):7072-8. PubMed ID: 3263899
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure.
Jain RK; Baxter LT
Cancer Res; 1988 Dec; 48(24 Pt 1):7022-32. PubMed ID: 3191477
[TBL] [Abstract][Full Text] [Related]
13. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
Roberts WG; Hasan T
Cancer Res; 1993 Jan; 53(1):153-7. PubMed ID: 8416739
[TBL] [Abstract][Full Text] [Related]
14. Improved pharmacokinetics and tumor localization of immunotoxins constructed with the Mr 30,000 form of ricin A chain.
Trown PW; Reardan DT; Carroll SF; Stoudemire JB; Kawahata RT
Cancer Res; 1991 Aug; 51(16):4219-25. PubMed ID: 1868442
[TBL] [Abstract][Full Text] [Related]
15. Disposition of the monoclonal antibody-vinca alkaloid conjugate KS1/4-DAVLB (LY256787) and free 4-desacetylvinblastine in tumor-bearing nude mice.
Spearman ME; Goodwin RM; Apelgren LD; Bumol TF
J Pharmacol Exp Ther; 1987 May; 241(2):695-703. PubMed ID: 3494841
[TBL] [Abstract][Full Text] [Related]
16. Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
Bradley MO; Webb NL; Anthony FH; Devanesan P; Witman PA; Hemamalini S; Chander MC; Baker SD; He L; Horwitz SB; Swindell CS
Clin Cancer Res; 2001 Oct; 7(10):3229-38. PubMed ID: 11595719
[TBL] [Abstract][Full Text] [Related]
17. Antibody-mediated versus nontargeted delivery in a human small cell lung carcinoma model.
Marecos E; Weissleder R; Bogdanov A
Bioconjug Chem; 1998; 9(2):184-91. PubMed ID: 9548533
[TBL] [Abstract][Full Text] [Related]
18. Diphtheria toxin effects on brain-tumor xenografts. Implications for protein-based brain-tumor chemotherapy.
Wrobel CJ; Wright DC; Dedrick RL; Youle RJ
J Neurosurg; 1990 Jun; 72(6):946-50. PubMed ID: 2159988
[TBL] [Abstract][Full Text] [Related]
19. A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma.
Vallera DA; Todhunter DA; Kuroki DW; Shu Y; Sicheneder A; Chen H
Clin Cancer Res; 2005 May; 11(10):3879-88. PubMed ID: 15897589
[TBL] [Abstract][Full Text] [Related]
20. A C terminus cysteine of diphtheria toxin B chain involved in immunotoxin cell penetration and cytotoxicity.
Dell'Arciprete L; Colombatti M; Rappuoli R; Tridente G
J Immunol; 1988 Apr; 140(7):2466-71. PubMed ID: 2965187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]